Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Biomed Environ Sci ; 31(6): 467-472, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30025561

RESUMO

There is still a need for better protection against or mitigation of the effects of ionizing radiation following conventional radiotherapy or accidental exposure. The objective of our current study was to investigate the possible roles of matrix metalloproteinase inhibitor, ilomastat, in the protection of mice from total body radiation (TBI), and the underlying protective mechanisms. Ilomastat treatment increased the survival of mice after TBI. Ilomastat pretreatment promoted recovery of hematological and immunological cells in mice after 6 Gy γ-ray TBI. Our findings suggest the potential of ilomastat to protect against or mitigate the effects of radiation.


Assuntos
Síndrome Aguda da Radiação/prevenção & controle , Raios gama/efeitos adversos , Ácidos Hidroxâmicos/uso terapêutico , Indóis/uso terapêutico , Inibidores de Metaloproteinases de Matriz/uso terapêutico , Lesões Experimentais por Radiação/prevenção & controle , Protetores contra Radiação/uso terapêutico , Síndrome Aguda da Radiação/sangue , Síndrome Aguda da Radiação/imunologia , Animais , Células Sanguíneas/efeitos dos fármacos , Células Sanguíneas/efeitos da radiação , Relação Dose-Resposta a Droga , Camundongos , Lesões Experimentais por Radiação/sangue , Lesões Experimentais por Radiação/imunologia , Baço/efeitos dos fármacos , Baço/imunologia , Baço/efeitos da radiação , Análise de Sobrevida , Irradiação Corporal Total
2.
Biomed Res Int ; 2019: 3924581, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31355259

RESUMO

This study investigated the effects of proanthocyanidins (PC) on arsenic methylation metabolism and efflux in human hepatocytes (L-02), as well as the relationships between PC and GSH, MRP1 and other molecules. Cells were randomly divided into blank control group, arsenic trioxide exposure group (ATO, As2O3, 25µmol/L), and PC-treated arsenic exposure group (10, 25, 50mg/L). After 24/48h, the contents of different forms of arsenic were determined, and the methylation indexes were calculated. Intracellular S-adenosyl methionine (SAM), arsenic (+3 oxidation state) methyltransferase (AS3MT), multidrug resistance-associated protein 1 (MRP1), and reduced glutathione (GSH) were ascertained. Changing trends were observed and the correlation between arsenic metabolism and efflux related factors and arsenic metabolites was analyzed. We observed that cells showed increased levels of content/constituent ratio of methyl arsenic, primary/secondary methylation index, methylation growth efficiency/rate, and the difference of methyl arsenic content in cells and culture medium (P<0.05, resp.). Compared with ATO exposure group, the intracellular SAM content in PC-treated group decreased, and the contents of GSH, AS3MT, and MRP1 increased (P<0.05, resp.). There was a positive correlation between the content of intracellular GSH/AS3MT and methyl arsenic. The content of MRP1 was positively correlated with the difference of methyl arsenic content in cell and culture medium; conversely, the SAM content was negatively correlated with intracellular methyl arsenic content (P<0.05, resp.). Taken together, these results prove that PC can promote arsenic methylation metabolism and efflux in L-02 cells, which may be related to the upregulation of GSH, MRP1, and AS3MT levels by PC.


Assuntos
Arsênio/metabolismo , Hepatócitos/efeitos dos fármacos , Oxirredução/efeitos dos fármacos , Proantocianidinas/farmacologia , Arsênio/química , Trióxido de Arsênio/química , Trióxido de Arsênio/metabolismo , Transporte Biológico , Regulação da Expressão Gênica/efeitos dos fármacos , Glutationa/genética , Humanos , Metilação/efeitos dos fármacos , Metiltransferases/genética , Proteínas Associadas à Resistência a Múltiplos Medicamentos/genética
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa